Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic risk factors for antiepileptic drug-induced hypersensitivity reactions in Israeli populations.

Epilepsia - 1 Oct 2016

Israel Shoshana, Maggio Nicola, Ekstein Dana, Zaid Huda, Firer Maria, Bederovsky Yana, Noyman Iris, Gandelman-Marton Revital, Blatt Ilan, Brautbar Chaim, Marom Eli, Nahlieli Dil Dorit, Berman Erez, Sabag David, Ingber Arieh, Eyal Sara

Abstract excerpt

The human leukocyte antigen (HLA) alleles B*15:02 and A*31:01 have been identified as predictive markers of adverse cutaneous effects of carbamazepine and phenytoin in Asian and North European populations, respectively. Our aim was to estimate the distribution of these alleles in Jewish and Arab populations in Israel. The HLA-B*15:02 and HLA-A*31:01 carrier rate was estimated based on data from the Hadassah Bone...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticonvulsants
Share to Arabs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Hypersensitivity

Share to Epilepsy

Share to HLA-A Antigens

Share to HLA-B Antigens

Share to Israel

Source

Identifiers

PMID: 27527795
DOI: 10.1111/epi.13498

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic risk factors for antiepileptic drug-induced hypersensitivity reactions in Israeli populations.PMID 27527795Read ↗

The risk of cutaneous adverse reactions among patients with the <i>HLA-A* 31:01</i> allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective reviewSemantic proximity Read ↗

The HLA-A*31:01 allele: influence on carbamazepine treatmentSemantic proximity Read ↗

HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese.Semantic proximity Read ↗

HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).Semantic proximity Read ↗

Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population.Semantic proximity Read ↗

Human leukocyte antigens and drug hypersensitivity.Semantic proximity Read ↗

HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.Semantic proximity Read ↗

An update on HLA alleles associated with adverse drug reactions.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 UpdateSemantic proximity Read ↗

Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese PopulationSemantic proximity Read ↗

HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.Semantic proximity Read ↗

Associations of HLA genetic variants with carbamazepine-induced cutaneous adverse drug reactions: An updated meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.